This Study supports SDGs 3, 5 and 10 by highlighting the significant variability in insurance coverage of Prophylactic Mastectomy (PM) between companies which can lead to further inequalities in access to this breast cancer risk reducing procedure. Physicians and patients alike should advocate for fair and equal access to PM for certain clinical indications.
This Article supports SDGs 3, 5 and 10, summarizing a discussion on workplace flexibility held by the AAWR at the RSNA 2021 Scientific Assembly and Annual Meeting, and highlighting the positive impact various aspects of flexible work arrangements have on women.
This Study supports SDGs 3, 5 and 10, investigating the impact of chemotherapy on the immune system of older women with breast cancer.
This Editorial highlights 17 contributions from outstanding women researchers in chemical engineering supporting SDG 5 (Gender equality) as well as SDG 9 (Industry, innovation and infrastructure).
This Article supports SDG 3 and 5 by demonstrating the need to better understand the roles that male partners play in encouraging or discouraging care-seeking behaviours during pregnancy and the postpartum period.
Batten Disease is a rare disease. This reviews highlights the existing sex bias and omissions in Batten Disease research.
This chapter advances goals 3 and 5 by covering the unique health issues and vulnerabilities of women.
This Article supports SDG 3 and 5 by highlighting a need for greater involvement of in-country authors on research examining a wider range of gendered COVID-19 impacts, as well as increased representation of diverse topics and publications related to COVID-19 and women's well-being focused on lower income countries.
This Study supports SDG 5 and 3 by examining the role of improved women's agency on the pathway from the intervention to nutritional impacts.
The authors posit that the consideration of equality, diversity and inclusion (EDI) principles is essential for research communities who wish for their work to represent the perspectives of those who will be affected by future novel technologies, in support of SDG 1.
